Immunoglobulin therapy providers are in the green premarket on the heels of the
FDA nod for emergency use of convalescent plasma for COVID-19.
Kamada (NASDAQ:
KMDA) (+23%), Grifols (NASDAQ:
GRFS) (+6%), XBiotech (NASDAQ:
XBIT) (+9%), Cerus (NASDAQ:
CERS) (+20%), ADMA Biologics (NASDAQ:
ADMA) (+70%)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.